OpenAlex
PricingAboutJobs
Log inGet started
Award

82472651

Funder: National Natural Science Foundation of China

Funded outputs count: 6
Funder award ID: 82472651
OpenAlex ID: G414606867
Phase III Trial: Single Low-Dose 5 mg Dexamethasone with NEPA for Preventing 168 h Nausea and Vomiting of Diverse Highly or Moderately Emetogenic Chemotherapy (LD-NEPA)
2026 · Yuting He, Xintian Huang, et al. · Diseases
FUCA2 Sustains AKT Signaling and Suppresses Senescence by Antagonizing FUT3‐Mediated ErbB3 Fucosylation in Lung Adenocarcinoma
2026 · Lu Chen, Jintao Guo, et al. · Advanced Science · 1
YTHDC1 drives senescence evasion in ovarian cancer through m6A-mediated TERT stabilization
2026 · Fen Wang, Zhengyang Zhao, et al. · Cell Death and Disease · 2
PDF
HNF4α-Mediated LINC02560 Promotes Papillary Thyroid Carcinoma Progression by Targeting the miR-505-5p/PDE4C Axis
2025 · Yongcheng Su, Beibei Xu, et al. · Biomolecules · 2
PDF
The Role of Long Non-Coding RNAs in Modulating the Immune Microenvironment of Triple-Negative Breast Cancer: Mechanistic Insights and Therapeutic Potential
2025 · Yongcheng Su, Qingquan Bai, et al. · Biomolecules · 13
Deeper Analysis to Identify the True Benefit of ICIs Immunotherapy in First-Line Treatment for Non-HER2-Positive/HER2-Negative Advanced or Metastatic Advanced or Metastatic Gastric Cancer (GC) or Gastroesophageal Junction Cancer (GEJC)
2025 · Bowen Zheng, Fanzhuoran Lou, et al. · Cancers
PDF
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security